![N-[4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phen](https://static.cymitquimica.com/products/3D/img/FE103676.png "Click to enlarge")
N-[4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phen
CAS: 1315330-11-0
Ref. 3D-FE103676
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire |
Product Information
N-[4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phen] (NEOF) is a potent inhibitor of the b-raf kinase and is used in cancer treatment. NEOF has been shown to inhibit epidermal growth factor receptor (EGFR)-mediated cell signaling, which may be due to its ability to induce autophagy. NEOF has also been shown to have cytotoxic effects on melanoma cells with BRAF mutations, which can lead to the death of these cells. The clinical relevance of NEOF in the treatment of skin cancer remains unclear.
NEOF has a linear pharmacokinetic profile in humans and is metabolized by cytochrome P450 enzymes before being excreted as a glucuronide conjugate. This drug binds tightly to plasma proteins (>99%) and has little potential for drug interactions due to its low protein binding affinity.
Chemical properties
Technical inquiry about: 3D-FE103676 N-[4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phen
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
